Mi Chunlei Makes Bold $38 Billion Move: Launches International Health City with Five Premium Medical Institutions
On December 6, Lanhai Investment announced that its indirect controlling shareholder, Lanhai Group, had signed a cooperation agreement with the People's Government of Yuxi City, Yunnan Province, and the People's Government of Chengjiang County, among other parties, regarding the “South Asia and Southeast Asia Medical Center and Ecological Health City Project.”This will become a crucial component of Lanhai Group’s adherence to the “Healthy China” strategy and its efforts to build an integrated medical and healthcare industry chain.
It is reported that the South Asia and Southeast Asia Medical Center and Ecological Health City have a total planned area of approximately 7,000 mu, with a total investment of about RMB 27.2 billion.The "South and Southeast Asia Medical Center and Ecological Health City Project" will be built on a high-quality, multi-dimensional, and international framework. By adopting an integrated model of medical care and health preservation, it aims to establish an international medical and ecological health city that integrates healthcare, scientific research, wellness, and eco-tourism residence. Rooted in Southwest China, serving the entire country, and extending its reach to South and Southeast Asian countries and regions.
Among these initiatives, the South and Southeast Asia Medical Center will comprehensively introduce high-quality medical resources and management concepts from both domestic and international sources. It aims to build a health industry cluster that includes large-scale international general hospitals, specialized hospitals such as cancer and rehabilitation hospitals, as well as research institutes, training institutions, and health management centers. The Eco-Health City will collaborate with renowned elderly care community service providers from Europe and the United States. Leveraging Yunnan’s abundant ethnic medicinal resources and the clinical technical advantages of this medical center, it will create an international, green, eco-friendly, low-density health and wellness town featuring rehabilitation and healthcare, leisure-oriented elderly care, and ethnic medicine.
Mi Chunlei, Chairman of the Board of Lanhai Holding Group and Chairman of Lanhai Investment, stated, “Establishing a South and Southeast Asian Medical Center and an Eco-Health City on the shores of Fuxian Lake is a key investment initiative by Lanhai to support the ‘Belt and Road Initiative’ and meet the multi-level, diversified demand for comprehensive health services among people in Southwest China as well as in South and Southeast Asia. The completion of this project will not only inject new momentum into Yuxi’s development but also help optimize Lanhai’s layout in the medical and healthcare industry, thereby achieving stronger self-development.”
It is reported that Lanhai Group is a large-scale comprehensive industrial group originating in Shanghai, serving China, and oriented toward the international market. Its core businesses include modern financial insurance, industrial investment, healthcare and wellness, and comprehensive automotive services. The group controls Lanhai Investment, a listed company focused on the healthcare industry. This listed entity specializes in operating high-end medical projects—including general hospitals, specialized hospitals, and comprehensive outpatient clinics—as well as online health management, committing to provide customers with high-quality, comprehensive professional diagnosis, treatment, and health services. Furthermore, as the largest shareholder of Shanghai Life Insurance Co., Ltd., Lanhai Group possesses inherent advantages and resources for the deep integration of the healthcare and financial insurance industries.
Currently, Lanhai Investment has sequentially established five medical institutions in Shanghai, including the soon-to-open Lujiazui Lanhai Medical Center, the upcoming Shanghai K11 Lanhai Medical Center, the Lanhai Bund International Hospital currently in preparation, and the Lanhai Rehabilitation Hospital and Orthopedic Hospital under construction within the New Hongqiao International Medical Park.
Lanhai Group stated that, upon completion, the Health City project will provide fundamental support for the sustainable development of its subsidiary Lanhai Investment’s core businesses in high-end healthcare, health management, and medical services. This will help enhance the visibility and influence of the Lanhai Medical brand, facilitate its expansion into South and Southeast Asian markets, and further broaden its strategic layout within the health industry platform.
Mi Chunlei’s foray into high-end healthcare can be traced back to last year.
On December 4, 2016, the listed company Lanhai Medical Industry Investment Co., Ltd. proposed to acquire a 95% equity stake in Hefeng Real Estate for RMB 1.235 billion in cash, and simultaneously planned to upgrade and renovate certain medical property assets of the Huangpu District Central Hospital (original site), a subsidiary of Hefeng Real Estate.
Through this transaction, Lanhai Medical will establish The Bund Hospital, an international high-end general hospital in the central urban area of Shanghai. This move will further enhance the company’s comprehensive layout across the entire healthcare industry chain, encompassing general and specialized medical diagnostics, general practice clinics, convalescence and rehabilitation services, and financial services for medical equipment. Furthermore, by integrating offline and online medical resources, the company aims to position itself as a publicly listed healthcare service platform featuring a full-industry-chain, three-dimensional model that combines both online and offline operations.
On the other hand, leveraging the advantages of Lanhai Group’s listed companies, Lanhai Medical Investment will more vigorously promote the comprehensive development of its healthcare business, injecting new vitality into China’s high-end medical and health market.
At that time, Mi Chunlei, Chairman of the Board of Lanhai Holding Group and Chairman of Lanhai Medical Investment, stated, “Going public has provided Lanhai Medical Investment with a broader platform for development. We have assembled a senior management team with extensive experience in the healthcare industry and high-level executives with years of multinational corporate management expertise, and we have established strategic collaborations with renowned medical institutions and industry-leading enterprises both domestically and internationally.”
Lanhai Medical Investment will benchmark itself against internationally leading medical services, leveraging its robust medical capabilities and global management perspective to strive for leadership in medical technology and healthcare services both domestically and abroad. It aims to build a world-class medical brand and contribute to the deepened development of China’s healthcare industry. As a publicly listed company, Lanhai Medical Investment will strictly adhere to listing regulations, delivering sustainable, stable, and healthy growth to reward its shareholders and society.
Currently, Lanhai Medical Investment’s rehabilitation hospital, oncology hospital, and high-end outpatient clinic projects are all progressing in an orderly manner and are expected to be completed and open for business soon.
In the future, Lanhai Medical Investment will focus on the healthcare industry, meticulously developing high-end medical projects—including premium outpatient clinics, specialized hospitals, and rehabilitation hospitals—as well as online health management services. It is committed to providing customers with high-quality, comprehensive professional diagnosis, treatment, and health services. Meanwhile, it also offers financial leasing services in the sectors of healthcare, intelligent manufacturing, and public utilities.
Lanhai Medical Investment will leverage the insurance industry resources of Lanhai Holdings Group to achieve an organic integration of high-end medical services and premium health insurance products, thereby building a comprehensive life-cycle health management industry chain. Committed to becoming a leader in domestic and international medical technology and healthcare services, it aims to establish a world-class medical brand and create value for all shareholders.